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Abstract
 .Pyruvate dehydrogenase PDH is regulated both by covalent modification and through modulation of the active enzyme
by metabolites. In the isolated heart, post-ischaemic inhibition of PDH, leading to uncoupling of glycolysis and glucose
oxidation and a decrease in cardiac efficiency, has been described. In vivo, post-ischaemic reperfusion leads to metabolic
abnormalities consistent with PDH inhibition, but the effects of ischaemiarreperfusion on PDH are not well characterized.
We therefore investigated PDH regulation following transient ischaemia in vivo. In 33 open-chest dogs, the left anterior
 .  .descending LAD was occluded for 20 min followed by 4 h reperfusion. In 17 dogs, dichloroacetate DCA was injected
prior to reperfusion, while 16 dogs served as controls. In dogs without DCA, glucose oxidation and lactate uptake were
lower in reperfused than in remote tissue, suggesting reduced flux through PDH. However, percent active and total PDH
measured in myocardial biopsies were similar in both territories, excluding covalent enzyme modification or loss of
functional enzyme. DCA activated PDH activity similarly in both regions and abolished differences in glucose oxidation
and lactate uptake. Thus, decreased PDH flux in reperfused myocardium does not result from covalent modification or loss
of total enzyme activity, but more likely from metabolite inhibition of the active enzyme. DCA leads to essentially complete
activation of PDH, increases overall glucose utilization and abolishes post-ischaemic inhibition of glucose oxidation.
q 1998 Elsevier Science B.V.
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1. Introduction
 .Pyruvate dehydrogenase PDH is a multi-enzyme
complex located at the inner mitochondrial mem-
brane, which plays a key role in regulating the flux of
glycolytic metabolites into the tricarboxylic acid
 .TCA cycle. This pivotal regulatory role of PDH is
reflected in the enzyme’s regulatory mechanisms.
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First, the enzyme contains an intrinsic kinaserphos-
phatase interconversion system where the kinase can
phosphorylate and thereby inactivate PDH. The ki-
nase is activated by NADH and acetyl CoA, and
inhibited by NADq, CoASH and ADP. Pyruvate acts
as a non-competitive inhibitor. Thus, the flux of
pyruvate into the TCA cycle is decreased by high
ratios of ATPrADP, NADHrNAD and acetyl-
CoArCoA, indicating an energy-rich cellular condi-
tion. Inactive, phosphorylated PDH is reactivated by
a specific phosphatase, which in turn is stimulated by
q w xcalcium and NAD , and inhibited by NADH 1–3 .
However, covalent modification alone cannot fully
explain the enzyme regulation. Several studies pro-
vided strong evidence for direct feedback inhibition
 .of the active dephosphorylated form of PDH by
w xNADH and acetyl CoA 4,5 . For instance, after
addition of fatty acids to perfused hearts, in which
PDH was fully activated, PDH flux i.e., pyruvate
.decarboxylation declined by 90% while the active
w xform of PDH decreased only 50% 4 . Thus, the PDH
 .complex is regulated by two distinct mechanisms: a
direct feedback inhibition by the products of the
 .reaction, and b by the kinaserphosphatase system.
Pharmacologically, PDH can be activated by dichlo-
 .racetate DCA , an inhibitor of PDH kinase.
In the isolated perfused heart, ischaemia per se had
no effect on the activation state of PDH, but reperfu-
sion led to a transient decrease in PDH activation
from 80 to 45% active, returning to normal levels
w xover 5 min 6 . The effects of ischaemia and reperfu-
sion on PDH in vivo are less well characterized, and
are potentially more complex. In the open-chest pig
heart, total PDH activity and the activation state were
unchanged at the end of 40 min regional ischaemia
w x7 . Administration of DCA led to a similar increase
in active PDH under normal aerobic and ischaemic
conditions. In contrast, in the brain, 10 min ischaemia
followed by reperfusion caused a large decrease in
w xtotal PDH activity that persisted for 24 h 8 ; the
activation state of the enzyme was not assessed.
The regulation of PDH in vivo in post-ischaemic
myocardium has not been described, but is potentially
important because metabolic abnormalities following
transient ischaemia and reperfusion are consistent
with a limitation of flux through PDH. These abnor-
malities include decreased lactate uptake, as well as
depressed oxidation of glucose, pyruvate and lactate
w x  .9,10 . Such an inhibition of PDH could reflect a
 .inactivation by phosphorylation; b regulation of the
 .active enzyme by metabolites; and c a decrease in
functional PDH as a result of degradation.
Therefore, the aim of this study was to determine
whether reperfusion after transient regional ischaemia
in canine myocardium leads to alterations in either
total PDH activity, or in the percentage of the en-
zyme in the active state. We further investigated if
lactate uptake and glucose oxidation, which were
found to be decreased post-ischaemia, could be nor-
malized by administration of the PDH kinase in-
hibitor DCA.
2. Methods
2.1. Animal preparation
Adult mongrel dogs, weighing 22–35 kg mean 27
.kg were studied according to the guidelines of the
University Animal Research Committee after an
overnight fasting. The animals were anaesthetized
 y1.with sodium thiopental Pentothal, 10 mg kg ,
endotracheally intubated, and ventilated with
oxygen-enriched room air to keep the arterial pH at
 .normal levels 7.35–7.45 . Anaesthesia was main-
tained by additional injections of pentothal as needed.
 .Morphine sulfate 10 mg was injected prior to
surgery and again at the end of the surgical proce-
dure. Two peripheral intravenous lines were inserted
for injection of drugs. The heart was exposed via a
left thoracotomy and suspended in a pericardial cra-
dle. The left atrium and the coronary sinus were
cannulated for microsphere injection and blood with-
drawal, respectively. The proximal left anterior de-
 .scending LAD coronary artery was dissected free
and a loose ligature was placed around it beyond the
first diagonal branch. The anterior interventricular
 .vein AIV was then cannulated distal to the LAD
artery occlusion site to allow venous blood sampling
selectively from the ischaemicrreperfused my-
ocardium. Left and right femoral arteries were ex-
posed, 7 F catheters inserted, and their tips advanced
into the abdominal aorta for arterial blood sampling
and continuous blood pressure recording Gould In-
.struments .
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2.2. Study protocol
Myocardial ischaemia was induced by transient
ligation of the LAD. Blood flow was measured with
microspheres, and substrate uptake and glucose oxi-
dation were measured invasively. Tissue biopsies
were assayed for PDH. Four groups of animals were
 .  .studied: 1 Group I ns17 : 20 min ischaemia
 .  .followed by 4 h reperfusion IrR ; 2 Group II
 .  y1 .ns16 : IrR plus DCA 150 mg kg i.v. prior to
 .  .reperfusion; 3 Group III ns7 : sham-operated
 .  .animals without DCA; and 4 Group IV ns7 :
sham-operated animals plus DCA.
Prior to ligation of the LAD, lidocaine 30 mg
.  y1bolus i.v. was injected. Lidocaine 1.5 mg kg
y1.h was infused during occlusion and early reperfu-
sion. DCA was infused during the last 5 min of the
occlusion period or sham occlusion period groups II
.and IV ; groups I and III received saline. Three
minutes prior to reperfusion procainamide 300 mg
.i.v. was injected to all groups.
After 20 min of occlusion, the LAD ligature was
released. A bolus of 20–30 mg lidocaine was injected
if reperfusion arrhythmias exceeded Lown class IIb.
At 3.5 h post-occlusion dogs in each group were
randomly divided into 2 subgroups: half of the ani-
mals underwent tissue biopsies for measurement of
PDH activity, while the remaining animals were used
to measure myocardial glucose oxidation with 14C-
glucose.
At the end of the study protocol, the animals were
terminated under deep anaesthesia with a bolus injec-
tion of saturated potassium chloride into the left
atrium. The heart was excised and cut into 1 cm thick
slices parallel to the base and perpendicular to the
long axis of the left ventricle. Slices were stained for
 . w xnecrotic tissue in triphenyltetrazolium TTC 11 ,
and then cut into pieces of 0.8–1.0 g each for mea-
surement of microsphere activity. TTC staining con-
firmed the absence of grossly necrotic tissue in all
studies.
2.3. Microsphere blood flow
Regional myocardial blood flow was determined
with radioactive microspheres at baseline 30 min
prior to LAD occlusion, during occlusion, and 90 min
and 3 h after reperfusion. In animals undergoing
measurements of glucose oxidation, myocardial blood
flow was also measured at the time of this study.
Polystyrene microspheres 15"0.3 mm diameter,
.DuPont, Wilmington, DE labeled with scandium
46 . 103 . 95 .Sc , ruthenium Ru , niobium Nb , tin
113 . 57 .Sn , and cobalt Co were injected into the left
atrium while arterial reference samples were with-
drawn simultaneously from the abdominal aorta
 y1.pump speed 7.2 ml min . Tissue samples were
counted in a well counter, and regional blood flow
was calculated by the arterial reference sample tech-
w xnique 12 . Post-ischaemic myocardium was identi-
fied by ligating the LAD and injecting dye into the
left atrium immediately prior to sacrifice.
2.4. Haemodynamic and metabolic data
Aortic pressure and heart rate were monitored
continuously throughout the study. Blood samples
were taken from the aorta, coronary sinus and the
AIV at baseline 30 min prior to LAD occlusion,
during occlusion, 90 min and 175 min after reperfu-
sion and, when performed, at the beginning and the
end of the 14C-glucose study. Blood from the AIV
was considered to represent the ischaemicrreper-
fused area, while coronary sinus blood was consid-
ered to represent remote myocardium; this will tend
to underestimate differences between remote and is-
chaemicrreperfused tissue, since coronary sinus
blood will contain blood from the ischaemicrreper-
fused tissue in addition to that from remote my-
ocardium.
Blood samples were analyzed for plasma glucose,
lactate, free fatty acids, and insulin by standard tech-
w xniques 13–15 . Blood gas values and haematocrit
were determined at baseline and during the LAD
occlusion, 90 min and 3 h after reperfusion, and
during 14C-glucose infusion. Regional substrate up-
take was calculated by means of the Fick principle.
2.5. Biopsy sampling and determination of pyru˝ate
( )dehydrogenase PDH
Transmural myocardial biopsies were taken from
the reperfused and remote regions with a high speed
 w .drill Dremel , 8000 rpm . Six biopsies each were
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taken progressively from the most distal part of these
territories towards the base of the heart, thus mini-
mizing disruption of blood flow to subsequent biop-
sies. Biopsy sites were closed by insertion of com-
pressed dried sponge plugs. Correct placement of
biopsy sites was confirmed postmortem by micro-
sphere blood flow of tissue samples containing biopsy
sites and by the pattern of dye. Biopsies were frozen
immediately in liquid nitrogen and later analyzed for
PDH activity.
Assay of PDH activity was carried out using the
w xradioisotope method of Olson et al. 4 . Briefly,
frozen biopsies were ground under liquid nitrogen
 and homogenized in a buffer 100 mM 3- N-morpho-
.lino propanesulphonic acid; 2.5 mM dithiothreitol;
.pH 7.0 using a motor-driven teflon pestle. Duplicate
samples were then used to determine total PDH
activity and the percentage of PDH in the active
form. One sample was incubated with 5 mM DCA in
the presence of calcium and magnesium prior to
assay to activate PDH and give the total tissue en-
zyme activity, PDH . The second sample was assayedt
under conditions maintaining the phosphorylation
state of the enzyme to give the activity present in the
tissue at the time of biopsy, PDHa. The activation
 .state, i.e., % active PDH, is given by PDH rPDHa t
=100.
2.6. Glucose oxidation
w 14 xTo measure glucose oxidation, U- C glucose
was infused into a peripheral vein bolus of 24 mCi,
followed by 15 mCi hy1, specific activity 3.46
.mCirmmol . Previous studies had shown that a time
period of 20 min is sufficient to reach plasma
14 w xsteady-state concentrations of C-glucose 16 .
Therefore, after 20 min for equilibration, blood sam-
ples were taken from the aorta, coronary sinus and
AIV. Samples were subsequently analyzed to deter-
14 w x 14mine the amount of CO produced 16 . The C-2
glucose concentrations in arterial and venous blood,
as well as the arterial glucose-specific activity were
stable between the 3 samples taken at 25, 35, and 45
min.
2.7. Statistical data analysis
Values are presented as mean"1 standard devia-
 .tion SD . Comparisons of data sets were performed
using Student’s t-test for paired data within one
group, the t-test for unpaired data for comparisons
between two groups, and by analysis of variance
 .ANOVA with Fisher’s PLSD for 3 and more groups.
A p value of -0.05 was considered significant.
3. Results
3.1. Haemodynamics and myocardial blood flow
There were no significant changes in either heart
rate or blood pressure in the control group without
 .DCA group III throughout the study period. In the
 .control plus DCA group IV , administration of
dichloracetate decreased heart rate and tended to
 .increase systolic blood pressure ps0.07 with no
significant change in the rate pressure product BP
Table 1
Haemodynamic parameters
Heart rate BP systolic Rate pressure
 .  .bpm mmHg product
Baseline
Group I 121"29 123"19 15.2"5.4
II 134"26 129"12 17.6"4.3
III 126"30 128"12 16.2"4.1
IV 136"30 145"11 19.5"4.2
Occlusion
)Group I 110"22 113"17 12.5"3.3
)II 121"24 121"14 14.8"3.5
III 126"48 128"12 16.0"6.1
IV 134"40 149"23 20.2"8.0
10 min reperfusion
Group I 102"9 111"14 11.4"3.2
a a aII 109"23 144"22 15.8"3.6
III 125"40 126"10 15.8"4.2
aIV 121"36 162"21 19.8"6.1
3 h reperfusion
Group I 114"35 114"19 13.3"5.5
II 133"22 127"16 17.0"4.3
III 127"47 131"8 16.7"6.0
IV 135"30 143"16 19.3"5.1
Values are mean"1 SD. bpm: beats per minute. BP: blood
pressure. Rate pressure productsbpm=BP systolic%1000. )p
-0.05 vs. baseline; ap-0.05 vs. occlusion.
See Section 2 for full description of groups.
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Fig. 1. Myocardial blood flow measured with radiolabeled micro-
 .spheres in the LAD territory and remote myocardium; A in
 .ischaemiarreperfusion groups and B in control groups; at base-
 .  .line I , during LAD occlusion square with diagonal lines and
 . )at 3 h reperfusion B ; p-0.01 vs. baseline and remote
myocardium during LAD occlusion.
.  .syst.=HR . In both IrR groups group I and II , the
rate pressure product was significantly depressed dur-
ing LAD occlusion and returned to baseline during
 .reperfusion Table 1 . A slight but significant in-
crease in the RPP was observed in the IrR plus DCA
group at reperfusion.
Microsphere measurements of myocardial blood
flow are shown in Fig. 1. Blood flow was stable
throughout the study protocol in the control groups
 .III and IV. In the IrR group I , flow in the LAD
territory decreased to 44"15% of that in remote
 .tissue during occlusion p-0.01 . It recovered to
80"13% of flow in remote tissue and remained at
this level for the remainder of the study. Findings
 .were similar in the IrR plus DCA group II , where
blood flow in the LAD territory was reduced to
45"12% vs. remote myocardium during occlusion
 .p-0.01 , and recovered to 90"15% during reper-
fusion. Flow in the remote myocardium remained
constant throughout the study.
3.2. Plasma substrate and insulin concentrations
Plasma concentrations of glucose, free fatty acids
and insulin were stable throughout the study, and did
not differ significantly between study groups Table
.2 . However, administration of DCA led to a signifi-
cant decrease in plasma lactate concentrations to 30%
of baseline levels in both groups II and IV.
3.3. Pyru˝ate dehydrogenase acti˝ity
Pyruvate dehydrogenase activity in myocardial tis-
sue biopsies from reperfused and remote myocardium
is shown in Fig. 2. There was no significant differ-
ence in total PDH activity between the two territories
Table 2
Arterial plasma concentrations of substrates and insulin
Baseline 1.5 h reperfusion 3 h reperfusion
y1( )Glucose mmol l
Group I 5.4"0.5 4.7"0.5 5.1"0.6
II 5.6"0.5 5.5"0.8 5.5"0.9
III 5.6"0.6 5.0"0.5 5.5"0.6
IV 5.7"1.0 5.4"1.2 5.5"0.9
y1( )Lactate mmol l
Group I 1.32"0.5 1.00"0.4 0.90"0.4
) )II 1.11"0.3 0.32"0.1 0.31"0.1
III 1.30"0.4 0.97"0.4 0.92"0.4
) )IV 0.9"0.3 0.28"0.1 0.27"0.1
y1( )Free fatty acids mEq l
Group I 0.22"0.07 0.24"0.08 0.24"0.09
II 0.14"0.03 0.14"0.03 0.12"0.04
III 0.24"0.05 0.20"0.05 0.16"0.05
IV 0.13"0.04 0.14"0.04 0.16"0.03
y1( )Insulin mU ml
Group I 15.8"4.3 8.2"2.8 8.4"4.3
II 14.1"7.8 11.7"6.6 11.0"6.0
III 19.0"9.0 8.75"2.8 10.8"5.0
IV 17.1"12 9.8"3.2 10.8"6.8
Values are mean"1 SD.
)ps0.001 vs. baseline.
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in any group or between groups. In animals without
DCA, PDH was approximately 50% active, and the
percentage of PDH present in the active state follow-
ing ischaemia and reperfusion was similar to that
found in sham-operated animals. There was no signif-
icant difference between post-ischaemic and remote
territories.
Administration of DCA induced a marked eleva-
tion of the percent active PDH in sham-operated
 .animals IV and similarly in the ischaemiarreperfu-
 .sion group II . Again, there was no difference be-
tween the post-ischaemic LAD territory and non-
ischaemic, remote myocardium.
3.4. Glucose oxidation
After ischaemia and reperfusion, glucose oxidation
in post-ischaemic tissue was significantly lower than
in remote myocardium reperfusion 0.09"0.05 vs.
y1 y1 .0.15"0.10 mmol min g p-0.01 . Administra-
tion of DCA stimulated glucose oxidation after is-
chaemiarreperfusion by 95"36% in the LAD terri-
 .tory p-0.05 and 40"21% in remote myocardium
 .p-0.05 , thereby eliminating regional differences
between post-ischaemic and remote myocardium Fig.
.3 . Glucose oxidation in sham-operated animals did
Fig. 3. Regional glucose oxidation in post-ischaemic square with
.  .diagonal lines and remote B myocardium 4 h after reperfusion
 .following LAD occlusionrreperfusion left panel and occlu-
 . )sionrreperfusion with administration of DCA right panel ; ps
0.03 for post-ischaemic vs. remote myocardium.
not show any regional differences and was signifi-
cantly enhanced by administration of DCA.
3.5. Net lactate uptake
 .After ischaemiarreperfusion group I , net lactate
uptake decreased by 60% in the post-ischaemic my-
 .  .  .Fig. 2. Total square with diagonal lines and active I PDH in control animals left panel and after LAD occlusion and reperfusion
 . )right panel . Numbers in bars give the % of PDH in the active form; pF0.01 for the amount of PDH in the active state after DCA
administration vs. without DCA.
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Table 3
Substrate uptake in reperfused and remote myocardium
Baseline 3 h Reperfusion
LAD Remote LAD Remote
y1 y 1( )Glucose mmol min g
Group I 0.14"0.11 0.15"0.10 0.14"0.08 0.15"0.09
) )II 0.21"0.12 0.19"0.12 0.38"0.12 0.40"0.14
III 0.18"0.03 0.19"0.08 0.15"0.03 0.18"0.03
) )IV 0.15"0.06 0.18"0.09 0.28"0.07 0.31"0.06
y1 y 1( )Lactate mmol min g
)aGroup I 0.19"0.07 0.21"0.11 0.08"0.09 0.18"0.13
) )II 0.22"0.17 0.21"0.14 0.02"0.02 0.03"0.02
III 0.19"0.06 0.19"0.05 0.16"0.02 0.16"0.02
) )IV 0.22"0.14 0.19"0.16 0.02"0.015 0.03"0.02
y1 y 1( )Free fatty acids mEq min g
Group I 0.030"0.01 0.028"0.01 0.028"0.01 0.030"0.01
II 0.028"0.01 0.022"0.007 0.021"0.01 0.021"0.01
III 0.032"0.01 0.024"0.007 0.028"0.01 0.026"0.01
IV 0.030"0.01 0.028"0.011 0.028"0.01 0.024"0.01
Values are mean"1 SD.
 .Substrate uptake was calculated as product of myocardial blood flow, arterio–venous substrate difference, and 1-hematocrit .
LAD and remote indicate respective territories.
)pF0.001 vs. baseline; apF0.01 vs. remote myocardium.
ocardium, from 0.19"0.07 at baseline to 0.08"0.10
y1 y1  .mmol min g at 3 h reperfusion ps0.001
 .Table 3 . In contrast, there was no significant change
in lactate uptake in remote myocardium 0.21"0.11
y1 y1.vs. 0.18"0.13 mmol min g , resulting in a
significant difference between LAD and remote terri-
 .tories. In the IrR plus DCA group II , lactate uptake
decreased significantly between baseline and 3 h
reperfusion; regional differences between remote and
post-ischaemic myocardium were abolished ps
.0.21 .
 .In both the sham-operated III and sham-operated
 .plus DCA group IV , net regional lactate uptake did
not differ between LAD and remote territory at any
 .point of time. As in the IrR group II , DCA also
decreased lactate uptake in controls.
3.6. Glucose uptake
Net glucose uptake at reperfusion was similar in
the post-ischaemic LAD territory and remote my-
ocardium in the IrR group 0.16"0.10 vs. 0.15"
y1 y1.  .0.09 mmol min g Table 3 . DCA treatment in
group II increased glucose uptake similarly and sig-
nificantly in both territories, to 0.38"0.11 and 0.41
"0.14 mmol miny1 gy1, respectively.
4. Discussion
Oxidation of glucose, pyruvate and lactate are
significantly lower in post-ischaemic than in normal
w xremote myocardium 9,10 , consistent with an inhibi-
tion of flux through PDH in post-ischaemic my-
ocardium. We demonstrate here that total PDH activ-
ity is unaffected by ischaemia and reperfusion, indi-
cating that flux inhibition cannot be explained by loss
of functional enzyme, for instance due to protein
degradation. In addition, the activation state of the
enzyme was similar in reperfused and remote my-
ocardium, indicating that impairment in glucose oxi-
dation in reperfused myocardium is not due to phos-
phorylation and inactivation of PDH.
4.1. Total PDH acti˝ity
In vitro studies have provided evidence that reac-
tive oxygen species, generated during reperfusion,
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w xcan cause PDH inactivation 17,18 . However, the
PDH enzyme complex is relatively insensitive to
H O -induced oxidative stress; oxidatively injured2 2
cardiomyocytes with a 90% inhibition of GAPDH
activity still retained more than 60% of their basal
w xPDH activity 17,18 . In addition, our data indicate
that if such radical-mediated PDH inactivation occurs
in myocardium in vivo, it can only be a short-term
phenomenon. The absence of a persistent decrease in
total myocardial PDH activity after reperfusion in the
present study differs from the decreased activity found
w xin cerebral tissue 8 , which may reflect tissue-specific
differences, or the greater degree of ischaemia zero-
.flow in the cerebral tissue relative to the cardiac
 .model 45% of baseline flow .
4.2. PDH regulation and effects of DCA
In the isolated heart, reperfusion after 10 min of
global no-flow ischaemia led to a rapid transient
decrease in PDH activity, with activity returning
w xtowards normal by 5 min post-reperfusion 6 . In the
present study, tissue biopsies were taken 4 h post-re-
perfusion to reflect sustained alterations of PDH rather
than transient modifications. The level of PDH activ-
ity was similar in sham-operated and ischaemiarre-
perfusion animals, approximately 50%, and no signif-
icant differences were found between reperfused and
remote tissue. DCA increased the PDH activation
state to approximately 90%. Similar results were
w xobtained in a recent study by Stanley et al. 7 , in
which tissue biopsies were taken before and at the
end of 40 min ischaemia in open-chest pigs; PDH
was approximately 55% active and showed a similar
response to DCA, and there were no significant
differences in PDH activation state between biopsies
w xtaken before and at the end of ischaemia 7 . Thus,
w xneither low-flow ischaemia 7 nor reperfusion after
 .transient ischaemia this study lead to significant
changes in total PDH activity or the activation state
of the enzyme in vivo.
The unchanged PDH activation state during low-
w xflow ischaemia 7 indicates that under physiological
conditions in vivo, PDH kinase is relatively insensi-
tive to changes in the acetyl-CoArCoA and
NADHrNAD ratios, both of which increase during
ischaemia and would cause activation of PDH kinase
and thus inhibition of PDH itself. It is likely that the
effects of acetyl CoA and NADH on PDH kinase are
offset by decreased ATPrADP leading to inhibition
w xof the kinase 6 .
Thus, while decreased CoA and increased NADH
and acetyl CoA also activate PDH kinase, inhibition
of the active enzyme may be more sensitive to
changes in metabolite concentrations than kinase reg-
ulation. In particular, the absence of changes in PDH
activation state suggests that the inhibition of lactate
and pyruvate oxidation during low-flow ischaemia
w x9 , and the decreased glucose oxidation and lactate
 .uptake in reperfused myocardium this study , reflect
primarily inhibition of active PDH by metabolites.
These potential regulators of the active PDH in-
clude acetyl-CoArCoASH, NADHrNAD and long-
w xchain acyl CoA 4,5,19 . Infusion of acetoacetate into
perfused hearts inhibited flux through PDH by 85%,
concomitant with a large increase in the acetyl-
CoArCoASH ratio, while the percentage of active
PDH was only marginally affected, falling from 56 to
w x43% 19 . These large effects of acetoacetate are
consistent with inhibition of PDH flux by decreased
availability of the substrate CoASH, since acetoac-
w xetate infusion leads to sequestration of CoASH 20 ,
and experiments in isolated mitochondria also sug-
gested the importance of free CoASH levels, both as
substrate and as a regulator of PDH kinase activity
w x19 . Since CoASH levels are also depressed in is-
w x w xchaemia 7 and reperfusion 21 , decreased CoASH
availability may contribute to PDH flux limitation in
these states. In addition, the stimulation of glucose
w xoxidation in the reperfused heart by carnitine 22
could also reflect relief of CoASH limitation of flux
through active PDH, since carnitine frees up CoASH.
Long-chain acyl CoA levels are also increased in
w xischaemia and reperfusion 22 . Since palmitoyl CoA
was shown to have a profound inhibitory effect on
active PDH, while having little effect on PDH kinase
w xactivity 19 , long-chain acyl CoA could also con-
tribute to inhibition of PDH flux in the absence of
changes in PDH activation state. Feedback inhibition
of PDH in isolated mitochondria was found to be
particularly pronounced in the presence of palmitoyl
carnitine, conditions that led to very low flux per unit
w xof enzyme 23 ; this may reflect either a direct effect
of long-chain fatty acid, or the low CoASH levels
prevailing.
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There is also evidence for persistent elevation of
NADH in reperfusion. In isolated rabbit hearts sub-
jected to ischaemia and reperfusion, tissue NADH
levels were increased 45 min post-reperfusion, while
in hearts treated with DCA, NADH levels were de-
w xcreased 24 . We recently found persistent elevation
of tissue lactaterpyruvate ratio in reperfused my-
ocardium, consistent with increased cytosolic
NADHrNAD ratios up to 3 h following reperfusion
w x25 . It is unclear, at present, whether similar changes
in the mitochondrial redox state are found following
reperfusion.
In the present study, activation of PDH with DCA
markedly increased glucose flux and abolished re-
gional differences in glucose oxidation and lactate
uptake, suggesting that inhibition of flux through
PDH in post-ischaemic myocardium is relieved when
the enzyme is converted to the fully active state by
DCA. The finding that stimulation of glucose oxida-
tion was greater in reperfused than remote my-
ocardium, despite a similar increase in PDH activity,
implies that DCA may be acting to stimulate glucose
oxidation at additional sites in reperfused my-
ocardium. In addition to its effects on PDH kinase,
DCA also mediates inhibition of fatty acid uptake
through indirect inhibition of carnitine palmitoyl
w xtransferase-I 26,7 . In the present study, FFA uptake
tended to decrease with DCA, but the changes were
not significant. This may reflect a trend towards
higher rate pressure products in DCA-treated animals,
leading to increased substrate demand and offsetting
inhibitory effects of DCA.
DCA decreased myocardial lactate uptake, proba-
bly reflecting decreased plasma lactate levels. DCA
also decreased NADH levels in reperfused my-
w xocardium 24 . Thus, increased flux through PDH in
response to DCA may reflect both covalent activation
of the enzyme by inhibition of PDH kinase and
alterations in tissue levels of regulatory metabolites
with direct effects on the active enzyme.
4.3. Functional significance
An imbalance between glycolysis and glucose oxi-
dation in reperfused myocardium results in excessive
w xproton production from glycolysis 27,28 . While the
small amount of ATP produced by glycolysis has
been proposed to be functionally compartmentalized
w xinto maintenance of sarcolemmal function 29 , the
benefits of this continuing ATP production during
ischaemiarreperfusion appear to be more than offset
by the production of protons from glycolysis leading
w xto decreased cardiac efficiency 28 . Factors con-
tributing to decreased cardiac efficiency in proton
overload may include increased proton–sodium ex-
change and sodium accumulation leading to
sodium–calcium exchange and calcium overload of
w xthe cell 28 , as well as a direct effect of acidosis on
w xcontractility 30 . On the other hand, stimulation of
glucose oxidation relative to glycolysis improves car-
w xdiac efficiency 28 and enhances functional recovery
in the isolated heart, an effect shared by DCA
w x27,28,31–33 and other treatments that increase glu-
w xcose oxidation, including carnitine 22 and ranola-
w xzine 34,35 . Our data indicate that, at least in our
animal model, PDH inactivation does not contribute
to the uncoupling of glycolysis and glucose oxida-
tion.
While functional recovery was not assessed in our
study, there is also evidence that DCA improves
post-ischaemic recovery of regional wall motion; in
canines subjected to repeated 10-min intervals of
ischaemia, DCA improved recovery of regional wall
w xmotion from 57% of baseline to 85% 36 .
4.4. Methodological considerations
4.4.1. Administration of DCA
In the present study, DCA was administered at the
end of the ischaemia period immediately before
w xreperfusion rather than before ischaemia 7,37 , be-
cause DCA administration prior to ischaemia might
increase lactate accumulation during the ischaemia
w xperiod 31 . Moreover, DCA was administered intra-
venously rather than by intracoronary injection as in
w x.other studies 34 to approximate more closely its
potential clinical use. This systemic administration
caused a profound decrease in plasma lactate concen-
trations that may be related to DCA-mediated activa-
w xtion of PDH in other organs 38,39 .
4.4.2. Measurements of glucose oxidation
Glucose oxidation was determined by production
14 w 14 xof CO from U- C -glucose; the data were not2
corrected for recirculation and subsequent oxidation
of secondarily labeled substrates, in particular lactate,
( )H. Schoder et al.rBiochimica et Biophysica Acta 1406 1998 62–72¨ 71
which will thus contribute to the production of 14CO .2
However, the error due to oxidation of secondarily
labeled substrates can be assumed to be small, and
would not change the conclusion that flux through
PDH was limited post-reperfusion; lactate oxidation
also proceeds through PDH after conversion of lac-
tate to pyruvate via lactate dehydrogenase.
5. Conclusion
Decreased glucose oxidation and lactate uptake in
post-ischaemic myocardium cannot be explained by
covalent inhibition of the PDH enzyme complex or
decreased overall PDH activity. Our findings rather
suggest inhibition of active PDH by metabolites as
the underlying mechanism for these metabolic alter-
ations. Administration of DCA completely activated
PDH and abolished regional differences in glucose
oxidation and lactate uptake.
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